Literature DB >> 18971079

Topical benzocaine-induced methemoglobinemia in the pediatric population.

Tsz-Yin So1, Elizabeth Farrington.   

Abstract

Topical benzocaine is an anesthetic agent that is often used before procedures and clinical tests, such as esophagoscopy, bronchoscopy, and endotracheal intubation. However, a potential deadly condition known as methemoglobinemia can occur with this agent. It causes the oxidation of hemoglobin to methemoglobinemia to occur more rapidly than the reduction of methemoglobin back to hemoglobin. Certain congenital and clinical conditions that affect oxygen delivery can increase the patient's risk of having methemoglobinemia develop with the use of benzocaine. Topical benzocaine-induced methemoglobinemia can occur in the pediatric population. Prompt management with intravenous methylene blue should be initiated for reversal.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18971079     DOI: 10.1016/j.pedhc.2008.08.008

Source DB:  PubMed          Journal:  J Pediatr Health Care        ISSN: 0891-5245            Impact factor:   1.812


  8 in total

1.  Atypical presentations of methemoglobinemia from benzocaine spray.

Authors:  Ekamol Tantisattamo; Nuntra Suwantarat; Joseph R Vierra; Samuel J Evans
Journal:  Hawaii Med J       Date:  2011-06

2.  Case files of the medical toxicology fellowship at Banner Good Samaritan Medical Center in Phoenix, AZ: methemoglobinemia following dapsone exposure.

Authors:  Joshua Canning; Michael Levine
Journal:  J Med Toxicol       Date:  2011-06

3.  Poly(lactide-co-glycolide) nanocapsules containing benzocaine: influence of the composition of the oily nucleus on physico-chemical properties and anesthetic activity.

Authors:  Nathalie Ferreira Silva de Melo; Renato Grillo; Viviane Aparecida Guilherme; Daniele Ribeiro de Araujo; Eneida de Paula; André Henrique Rosa; Leonardo Fernandes Fraceto
Journal:  Pharm Res       Date:  2011-04-07       Impact factor: 4.200

Review 4.  Methylene blue for distributive shock: a potential new use of an old antidote.

Authors:  David H Jang; Lewis S Nelson; Robert S Hoffman
Journal:  J Med Toxicol       Date:  2013-09

5.  Synthesis, characterization, antibacterial evaluation, 2D-QSAR modeling and molecular docking studies for benzocaine derivatives.

Authors:  Israa Taha; Eman M Keshk; Abdel-Galil M Khalil; Ahmed Fekri
Journal:  Mol Divers       Date:  2020-09-25       Impact factor: 2.943

6.  Methemoglobinemia caused by dapsone overdose: Which treatment is best?

Authors:  Ibrahim Toker; Murat Yesilaras; Feriyde Caliskan Tur; Rana Toktas
Journal:  Turk J Emerg Med       Date:  2016-03-09

7.  Pediatric Exposures to Topical Benzocaine Preparations Reported to a Statewide Poison Control System.

Authors:  Rais Vohra; Serena Huntington; Jennifer Koike; Kevin Le; Richard J Geller
Journal:  West J Emerg Med       Date:  2017-07-14

8.  Determination of Benzocaine in Pharmaceutical Formulations by Indirect SERRS Assay Combined with Azo Coupling.

Authors:  Chao-Yang Zhao; Huimin Sui; Endi Xue; Li Li; Jie Zhang; Tao Xu; Xin Liang; Ying Yang
Journal:  Molecules       Date:  2022-07-14       Impact factor: 4.927

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.